☆ 4.5 Article

Case report: Virus-induced hemophagocytic lymphohistiocytosis in a patient with APECED

FRONTIERS IN PEDIATRICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Immunology

AIRE gene mutation predisposing chronic mucocutaneous candidiasis and pigmented retinitis in two kids from a Chinese family

Yubo Ma et al.

EMERGING MICROBES & INFECTIONS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

APECED-Associated Hepatitis: Clinical, Biochemical, Histological and Treatment Data From a Large, Predominantly American Cohort

David M. Chascsa et al.

Summary: The study found that APAH is more common than previously described, may present early before classic APECED manifestations, and most often manifests with milder, treatment-responsive disease. Several APECED-associated autoantibodies, but not standard AIH-associated biomarkers, correlate with APAH.

HEPATOLOGY (2021)

添加到收藏夹

Review Immunology

Infections in the monogenic autoimmune syndrome APECED

Vasileios Oikonomou et al.

Summary: APECED is caused by mutations in the AIRE gene leading to autoimmune attacks on multiple tissues and increased susceptibility to specific infections such as CMC and COVID-19.

CURRENT OPINION IN IMMUNOLOGY (2021)

添加到收藏夹

Review Rheumatology

Immune cartography of macrophage activation syndrome in the COVID-19 era

Dennis McGonagle et al.

Summary: This article discusses macrophage activation syndrome (MAS) in relation to other cytokine storm scenarios, providing a framework for understanding MAS within the spectrum of innate and adaptive immunity in the context of gain or loss of immune function.

NATURE REVIEWS RHEUMATOLOGY (2021)

添加到收藏夹

Article Immunology

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

Paul Bastard et al.

Summary: Patients with biallelic loss-of-function variants of AIRE, suffering from APS-1, produce autoantibodies that neutralize most type I interferons, leading to a significantly increased risk of life-threatening COVID-19 pneumonia. Research has shown that in APS-1 patients with these neutralizing autoantibodies, 86% developed COVID-19 pneumonia.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

添加到收藏夹

Article Cell Biology

Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19

Michael S. Abers et al.

Summary: This study compared clinical outcomes between patients with neutralizing type-I interferon autoantibodies (AAbs) and those without AAbs during hospitalization for COVID-19, revealing that patients with AAbs were more likely to be admitted to the intensive care unit with delayed viral clearance, although their survival was not adversely affected.

IMMUNOLOGY AND CELL BIOLOGY (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients

Elise M. N. Ferre et al.

Summary: Treatment with bamlanivimab and etesevimab in APECED patients may have potential benefits, as early administration can improve COVID-19 symptoms and prevent disease progression, without affecting the production of antibodies to the nucleocapsid protein of SARS-CoV-2.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

AIRE Gene Mutation Presenting at Age 2 Years With Autoimmune Retinopathy and Steroid-Responsive Acute Liver Failure: A Case Report and Literature Review

Hirotaka Sakaguchi et al.

Summary: APECED is a rare monogenic autosomal recessive disorder caused by mutation in the AIRE gene. Patients are usually diagnosed between the ages of 5 and 15, with manifestations including mucocutaneous candidiasis, Addison's disease, and hypoparathyroidism. APAH occurs in only 10% to 40% of patients, with severity ranging from subclinical chronic active hepatitis to potentially fatal acute liver failure.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths

Paul Bastard et al.

Summary: Autoantibodies neutralizing interferons are present in a significant percentage of critical COVID-19 patients, especially in older individuals, and their prevalence increases with age.

SCIENCE IMMUNOLOGY (2021)

添加到收藏夹

Review Pediatrics

Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management

Lauren A. Henderson et al.

PEDIATRIC DRUGS (2020)

添加到收藏夹

Article Hematology

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

Matthew J. Frigault et al.

BLOOD (2020)

添加到收藏夹

Letter Endocrinology & Metabolism

A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor

G. Beccuti et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)

添加到收藏夹

Review Oncology

Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)

Michael B. Jordan et al.

PEDIATRIC BLOOD & CANCER (2019)

添加到收藏夹

Article Cell Biology

Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance

Elise M. N. Ferre et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

添加到收藏夹

Article Oncology

Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study

Xiao-Jun Xu et al.

PEDIATRIC BLOOD & CANCER (2017)

添加到收藏夹

Review Ophthalmology

Ocular manifestations of autoimmune polyendocrinopathy syndrome type 1

Aude Couturier et al.

CURRENT OPINION IN OPHTHALMOLOGY (2016)

添加到收藏夹

Article Rheumatology

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Angelo Ravelli et al.

ARTHRITIS & RHEUMATOLOGY (2016)

添加到收藏夹

Article Ophthalmology

Retinal degeneration in autoimmune polyglandular syndrome type 1: a case series

Serge Bourgault et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2015)

添加到收藏夹

Article Hematology

The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis

Sebastian F. N. Bode et al.

HAEMATOLOGICA (2015)

添加到收藏夹

Article Hematology

The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis

Sebastian F. N. Bode et al.

HAEMATOLOGICA (2015)

添加到收藏夹

Article Hematology

Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens

DeepakBabu Chellapandian et al.

BRITISH JOURNAL OF HAEMATOLOGY (2013)

添加到收藏夹

Review Gastroenterology & Hepatology

Gastrointestinal Manifestations in APECED Syndrome

Nicolas Kluger et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

A case of EBV driven haemophagocytic lymphohistiocytosis complicating a teenage Crohn's disease patient on azathioprine, successfully treated with rituximab

Michael P. Fitzgerald et al.

JOURNAL OF CROHNS & COLITIS (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen

Mohammad Alimohammadi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

添加到收藏夹

Article Hematology

Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes

Kai Kisand et al.

BLOOD (2008)

添加到收藏夹

Review Oncology

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

Jan-Inge Henter et al.

PEDIATRIC BLOOD & CANCER (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.